Pulmonary hypertension therapy and COPD: still many questions to be answered.


Autoria(s): Cottin V.; Khouatra C.; Lazor R.; Canu P.; Cordier J.F.
Data(s)

2009

Identificador

http://serval.unil.ch/?id=serval:BIB_F56D69394129

isbn:1399-3003[electronic]

pmid:19181926

doi:10.1183/09031936.00161808

isiid:000263709300040

Idioma(s)

en

Fonte

European Respiratory Journal, vol. 33, no. 2, pp. 450-452; author reply 452-453

Palavras-Chave #Antihypertensive Agents/pharmacology; Humans; Hypertension, Pulmonary/complications; Hypertension, Pulmonary/drug therapy; Lung/drug effects; Pulmonary Artery/pathology; Pulmonary Disease, Chronic Obstructive/complications; Pulmonary Disease, Chronic Obstructive/pathology; Research Design; Sulfonamides/pharmacology; Treatment Outcome
Tipo

info:eu-repo/semantics/article

article